Walter Reed Army Medical Center
Welcome,         Profile    Billing    Logout  
 48 Trials 
18 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cohen, Steven J
DETeR, NCT04563299: Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

Terminated
4
10
US
Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate
Retina Vitreous Associates of Florida, Ocular Therapeutix, Inc.
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
02/23
02/23
CIRCULATE-US, NCT05174169: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Recruiting
2/3
1912
Canada, US
Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month, mFOLFIRINOX, mFOLFOX6 6 month, CAPOX 6 month
NRG Oncology, Natera, Inc., National Cancer Institute (NCI)
Stage III Colon Cancer
03/29
03/30
NCT04378959: Lidocaine Patch for Neck Pain

Completed
N/A
76
US
Lidocaine patch, Placebo patch
Johns Hopkins University, Washington D.C. Veterans Affairs Medical Center, Pain Management Institute Bethesda-Washington-Maryland, Walter Reed National Military Medical Center, Scilex Pharmaceuticals, Inc.
Neck Pain, Neck Pain, Posterior
06/23
06/23
NCT06169670: Autologous Fat Grafting to the Face With Use of the Viality™ System

Recruiting
N/A
20
US
Viality
Sientra, Inc., Faces+
Adipose Tissue
01/25
03/25
Wortmann, Glenn
REPAVID-22, NCT05254990 / 2021-006951-32: Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Terminated
3
409
Europe, US, RoW
Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo
Dompé Farmaceutici S.p.A
Infectious Pneumonia, Severe COVID-19
09/24
09/24
RESOLUTION, NCT04417257: Study of LAU-7b for the Treatment of COVID-19 Disease in Adults

Completed
2/3
125
Canada, US
LAU-7b, fenretinide, Placebo oral capsule
Laurent Pharmaceuticals Inc.
COVID-19 Disease
02/24
05/24
APT.DFO.001, NCT05177107: Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

Recruiting
2b
126
US
Phage Therapy, Placebo
Adaptive Phage Therapeutics, Inc., United States Department of Defense
Osteomyelitis, Diabetic Foot Osteomyelitis
04/24
12/24
King, Christopher R
TETON, NCT04708782: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Hourglass May 2024 - Aug 2024 : Topline data for IPF
Hourglass Jan 2023 - Mar 2023 : Enrollment completion of TETON trial for IPF
Recruiting
3
576
Canada, US
Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer
United Therapeutics
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
06/25
06/25
TETON-PPF, NCT05943535: Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis

Recruiting
3
698
Canada, US, RoW
Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer
United Therapeutics
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
11/27
11/27
FOSTA-ARDS, NCT06564207: Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults

Not yet recruiting
2
40
NA
Placebo, Fostamatinib, fostamatinib disodium
Inova Health Care Services, Rigel Pharmaceuticals, Biomedical Advanced Research and Development Authority
Acute Respiratory Distress Syndrome, ARDS
08/25
10/25
Villines, Todd C
NCT06018194: ELUCIDATE FFRct Study

Recruiting
N/A
350
US
ElucidVivo
Elucid Bioimaging Inc., Lundquist Institute at Harbor-UCLA Medical Center
Coronary Artery Disease
07/24
07/24
PARAMOUNT, NCT06713239: A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

Not yet recruiting
N/A
1000
NA
Cleerly Labs and Cleerly ISCHEMIA
Cleerly, Inc.
Coronary Artery Disease
12/25
12/25
CONFIRM2, NCT04279496: Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry

Enrolling by invitation
N/A
35000
US
Cleerly, Inc.
Coronary Artery Disease
06/27
06/27
Laubach, Susan
NCT03878069: Registry Study of Revcovi Treatment in Patients With ADA-SCID

Completed
N/A
32
US
elapegademase-lvlr, Revcovi
Chiesi Farmaceutici S.p.A.
Adenosine Deaminase Severe Combined Immunodeficiency
01/23
01/23
Fraser, Jamie A
NCT03047369: The Myelin Disorders Biorepository Project

Recruiting
N/A
12000
US
Children's Hospital of Philadelphia, National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), National Center for Advancing Translational Sciences (NCATS), Biogen, Eli Lilly and Company, Myrtelle Inc., Orchard Therapeutics Ltd., Passage Bio, Inc., Synaptix Biotherapeutics Ltd., Takeda, Boehringer Ingelheim, Ionis Pharmaceuticals, Inc., Sanofi Winthrop Industrie, Sana Biotechnology, Yaya Foundation for 4H Leukodystrophy, University of Pennsylvania, United MSD Foundation, Foundation to Fight H-ABC, Calliope Joy Foundation, Don't Forget Me Foundation
Leukodystrophy, White Matter Disease, Leukoencephalopathies, 4H Syndrome, Adrenoleukodystrophy, AMN, ALD, ALD Gene Mutation, ALD (Adrenoleukodystrophy), X-linked Adrenoleukodystrophy, X-ALD, Adrenomyeloneuropathy, Aicardi Goutieres Syndrome, AGS, Alexander Disease, Alexanders Leukodystrophy, AxD, ADLD, Canavan Disease, CTX, Cerebrotendinous Xanthomatoses, Krabbe Disease, GALC Deficiency, Globoid Leukodystrophy, TUBB4A-Related Leukodystrophy, H-ABC - Hypomyelination, Atrophy of Basal Ganglia and Cerebellum, HBSL, HBSL - Hypomyelination, Brain Stem, Spinal Cord, Leg Spasticity, LBSL, Leukoencephalopathy With Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder), Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation, ALSP, CSF1R Gene Mutation, HCC - Hypomyelination and Congenital Cataract, MLC1, Megalencephalic Leukoencephalopathy With Subcortical Cysts, MLD, Metachromatic Leukodystrophy, PMD, Pelizaeus-Merzbacher Disease, PLP1 Null Syndrome, PLP1 Gene Duplication | Blood or Tissue | Mutations, Pelizaeus Merzbacher Like Disease, Peroxisomal Biogenesis Disorder, Zellweger Syndrome, Refsum Disease, Salla Disease, Sialic Storage Disease, Sjögren, Sjogren-Larsson Syndrome, Van Der Knapp Disease, Vanishing White Matter Disease, Charcot-Marie-Tooth, CMT, Mct8 (Slc16A2)-Specific Thyroid Hormone Cell Transporter Deficiency, Allan-Herndon-Dudley Syndrome, Cadasil, Cockayne Syndrome, Multiple Sulfatase Deficiency, Gangliosidoses, GM2 Gangliosidosis, BPAN, Labrune Syndrome, LCC, Mucopolysaccharidoses, TBCK-Related Intellectual Disability Syndrome
12/30
12/30
Wilson, William H
CIRCULATE-US, NCT05174169: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Recruiting
2/3
1912
Canada, US
Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month, mFOLFIRINOX, mFOLFOX6 6 month, CAPOX 6 month
NRG Oncology, Natera, Inc., National Cancer Institute (NCI)
Stage III Colon Cancer
03/29
03/30
A071401, NCT02523014: Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients with Progressive Meningiomas

Recruiting
2
124
US
Vismodegib, GDC-0449, FAK Inhibitor GSK2256098, Capivasertib, AZD5363, Abemaciclib
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), GlaxoSmithKline, Genentech, Inc., Brain Science Foundation
Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation
01/26
01/28
NCT05674344: Calibration and Validation of the Masimo Temperature Device in Febrile Patients

Completed
N/A
170
US
Masimo Temperature device
Masimo Corporation
Fever
03/23
03/23
Schneider, Bret
No trials found

Download Options